🆚 IP-API vs. ipdata

Compare technologies based on real-world usage data *

Type

Geolocation tool
Geolocation tool

About

IP-API is an IP geolocation API that offers a limited free tier and a paid pro service.

ipdata provides an IP Geolocation and Threat Intelligence API.

Headquarters

Bucharest, Romania
Newark, Delaware, United States

Website

Pricing

Free version ✔️45 requests/minute, non-commercial use only
Pro€159.6/year
Free version ✔️1,500 requests daily
Personal
(2.5K requests daily)
$10/month
Lite
(10K requests daily)
$30/month
Startup
(50K requests daily)
$50/month
Business
(100K requests daily)
$120/month

Categories

Geolocation › Rank #6
Geolocation › Rank #9

Popularity

Determined by the number of sites using each technology.

The IP-API geolocation tool is 4 times more popular than ipdata.
Total websites

Market share

Geolocation

Popularity by country

Determined by the number of sites detected from each country.

IP-API is more popular in the United States, Russia, and the United Kingdom, while ipdata is more popular in the United Arab Emirates, Hong Kong, and Uruguay.
United States
Russia
United Kingdom
India
Germany
Australia
Netherlands
Brazil
Canada
Sweden

Awards

Popularity by domain category

Determined by the number of sites in each category.

IP-API is more popular among sites focused on business, marketing and merchandising, and online shopping, while ipdata is more commonly used on travel and real estate sites.
Business
Marketing/Merchandising
Online Shopping
Blogs/Wiki
Travel
Software/Hardware
Internet Services
Real Estate
General News
Finance/Banking

Top sites

Top-ranked sites that use these technologies.

Name
Rank
View more ➝
Name
Rank
#2,083
#8,508
#12,165
#16,372
#23,173
View more ➝

See also

* According to recent studies, many of online reviews are fake.
When making your decision, it is better to rely on data that cannot be falsified.
Our service evaluates the popularity of technologies by the number of websites using them.

Statistics were last calculated on .
For details, see our methodology and disclaimer.